**Core Concept**
The management of diabetes mellitus in patients with congestive heart failure (CHF) requires careful consideration of medications to avoid exacerbating heart failure. The goal is to balance glycemic control with the risk of worsening heart failure.

**Why the Correct Answer is Right**
In patients with diabetes and CHF, loop diuretics (such as furosemide) are typically used to manage fluid overload. However, another class of medications, **thiazide diuretics**, can worsen CHF by decreasing the levels of potassium and magnesium, which can lead to digitalis toxicity and worsening heart failure. Moreover, thiazide diuretics can also increase glucose levels, which is undesirable in diabetic patients.

**Why Each Wrong Option is Incorrect**
* **Option A:** Metformin is a first-line medication for type 2 diabetes and is not contraindicated in CHF. It works by decreasing hepatic glucose production and increasing insulin sensitivity.
* **Option B:** Angiotensin-converting enzyme (ACE) inhibitors are actually beneficial in patients with CHF, as they reduce afterload and decrease the progression of heart failure.
* **Option C:** Beta-blockers, such as carvedilol, are also beneficial in CHF and are not contraindicated in diabetic patients. They reduce sympathetic tone and decrease morbidity and mortality in CHF.

**Clinical Pearl / High-Yield Fact**
When managing diabetes in patients with CHF, it's essential to consider the potential interactions between medications and the risk of worsening heart failure. Always choose medications that have a favorable effect on glycemic control and cardiovascular outcomes.

**Correct Answer:** D. Thiazide diuretics